Screener
Beam Therapeutics BEAM Market capitalization
Market capitalization at other companies
Other financials
Where this comes from
Computed from the period-end share price: $2.43B.
The source filing: Beam Therapeutics’s 10-Q, filed May 7, 2026. Open the filing →
- Filed
- May 7, 2026, 7:22 AM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001193125-26-210338
FAQ
- What is Beam Therapeutics's market capitalization?
- Beam Therapeutics (BEAM) reported market capitalization of $2.43B in Q1 2026.
- How has Beam Therapeutics's market capitalization changed year-over-year?
- Beam Therapeutics's market capitalization increased by 24.5% year-over-year, from $1.95B to $2.43B.
- What is the long-term trend for Beam Therapeutics's market capitalization?
- Over 5 years (2020 to 2025), Beam Therapeutics's market capitalization has grown at a -12.7% compound annual growth rate (CAGR), from $5.56B to $2.81B.
- What does market capitalization mean?
- The total market value of the company's equity at the quarter end (share price × shares outstanding), sampled from daily market data. The latest point tracks the live price.
Ask your AI about Beam Therapeutics's market capitalization.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude